During the past decade, Philadelphia Eye Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philadelphia Eye Associates" #1 sponsor was "Mati Therapeutics Inc." with 2 trials, followed by "Philadelphia Eye Associates" with 2 trials sponsored, "AcuFocus, Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Faes Farma, S.A." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philadelphia Eye Associates" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Thomas Jefferson University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Philadelphia Eye Associates" are "Ocular Hypertension" (3 trials), "Blepharitis" (2 trials), "Glaucoma" (2 trials), "Open-Angle Glaucoma" (2 trials) and "Allergic Conjunctivitis" (1 trials). Many other conditions were trialed in "Philadelphia Eye Associates" in a lesser frequency.

Most popular intervention types in "Philadelphia Eye Associates" are "Drug" (10 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azasite" (2 trials), "Placebo" (2 trials), "Azithromycin ophthalmic solution, 1%" (1 trials), "Bilastine Ophthalmic Solution 0.6%" (1 trials) and "Control Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Philadelphia Eye Associates" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Philadelphia Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Philadelphia Eye Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Philadelphia Eye Associates, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".